Overall, this is one of the few studies showing that GIP signaling is altered by the gut microbiome, and it supports that the positive effect of bariatric surgery on NAFLD is in part due to microbiome changes. The gene discussed is GIP; the disease is metabolic dysfunction-associated steatotic liver disease.